Summary
The global Amebiasis Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Amebiasis Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Amebiasis Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Dr. Reddys Laboratories
- Mission Pharmacal
- Aceto Corporation
- Mylan Pharmaceuticals
- Impax Laboratories
- Pfizer
- Sanofi
- Lupin Pharmaceuticals
- Glenmark Pharmaceuticals
- Sun Pharmaceutical
- Heritage Pharmaceuticals
By the Product Type, the market is primarily segmented into:
- Metronidazole
- Paromomycin
- Tinidazole
- Other
By Applications, the market is segmented into:
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Amebiasis Market Report:
- To assess the size of the market by value and volume
- Analyze the Amebiasis Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Amebiasis Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Amebiasis Market
The Amebiasis Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Amebiasis Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
1 Study Coverage
1.1 Amebiasis Product Introduction
1.2 Market Segments
1.3 Key Amebiasis Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Amebiasis Market Size Growth Rate by Type
1.4.2 Metronidazole
1.4.3 Paromomycin
1.4.4 Tinidazole
1.4.5 Other
1.5 Market by Application
1.5.1 Global Amebiasis Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmacy
1.6 Coronavirus Disease 2019 (Covid-19): Amebiasis Industry Impact
1.6.1 How the Covid-19 is Affecting the Amebiasis Industry
1.6.1.1 Amebiasis Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Amebiasis Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Amebiasis Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Amebiasis Market Size Estimates and Forecasts
2.1.1 Global Amebiasis Revenue 2015-2026
2.1.2 Global Amebiasis Sales 2015-2026
2.2 Amebiasis Market Size by Region: 2020 Versus 2026
2.2.1 Global Amebiasis Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Amebiasis Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Amebiasis Competitor Landscape by Players
3.1 Amebiasis Sales by Manufacturers
3.1.1 Amebiasis Sales by Manufacturers (2015-2020)
3.1.2 Amebiasis Sales Market Share by Manufacturers (2015-2020)
3.2 Amebiasis Revenue by Manufacturers
3.2.1 Amebiasis Revenue by Manufacturers (2015-2020)
3.2.2 Amebiasis Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Amebiasis Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Amebiasis Revenue in 2019
3.2.5 Global Amebiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Amebiasis Price by Manufacturers
3.4 Amebiasis Manufacturing Base Distribution, Product Types
3.4.1 Amebiasis Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Amebiasis Product Type
3.4.3 Date of International Manufacturers Enter into Amebiasis Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Amebiasis Market Size by Type (2015-2020)
4.1.1 Global Amebiasis Sales by Type (2015-2020)
4.1.2 Global Amebiasis Revenue by Type (2015-2020)
4.1.3 Amebiasis Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Amebiasis Market Size Forecast by Type (2021-2026)
4.2.1 Global Amebiasis Sales Forecast by Type (2021-2026)
4.2.2 Global Amebiasis Revenue Forecast by Type (2021-2026)
4.2.3 Amebiasis Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Amebiasis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Amebiasis Market Size by Application (2015-2020)
5.1.1 Global Amebiasis Sales by Application (2015-2020)
5.1.2 Global Amebiasis Revenue by Application (2015-2020)
5.1.3 Amebiasis Price by Application (2015-2020)
5.2 Amebiasis Market Size Forecast by Application (2021-2026)
5.2.1 Global Amebiasis Sales Forecast by Application (2021-2026)
5.2.2 Global Amebiasis Revenue Forecast by Application (2021-2026)
5.2.3 Global Amebiasis Price Forecast by Application (2021-2026)
6 North America
6.1 North America Amebiasis by Country
6.1.1 North America Amebiasis Sales by Country
6.1.2 North America Amebiasis Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Amebiasis Market Facts & Figures by Type
6.3 North America Amebiasis Market Facts & Figures by Application
7 Europe
7.1 Europe Amebiasis by Country
7.1.1 Europe Amebiasis Sales by Country
7.1.2 Europe Amebiasis Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Amebiasis Market Facts & Figures by Type
7.3 Europe Amebiasis Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Amebiasis by Region
8.1.1 Asia Pacific Amebiasis Sales by Region
8.1.2 Asia Pacific Amebiasis Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Amebiasis Market Facts & Figures by Type
8.3 Asia Pacific Amebiasis Market Facts & Figures by Application
9 Latin America
9.1 Latin America Amebiasis by Country
9.1.1 Latin America Amebiasis Sales by Country
9.1.2 Latin America Amebiasis Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Amebiasis Market Facts & Figures by Type
9.3 Central & South America Amebiasis Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Amebiasis by Country
10.1.1 Middle East and Africa Amebiasis Sales by Country
10.1.2 Middle East and Africa Amebiasis Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Amebiasis Market Facts & Figures by Type
10.3 Middle East and Africa Amebiasis Market Facts & Figures by Application
11 Company Profiles
11.1 Dr. Reddys Laboratories
11.1.1 Dr. Reddys Laboratories Corporation Information
11.1.2 Dr. Reddys Laboratories Description, Business Overview and Total Revenue
11.1.3 Dr. Reddys Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Dr. Reddys Laboratories Amebiasis Products Offered
11.1.5 Dr. Reddys Laboratories Recent Development
11.2 Mission Pharmacal
11.2.1 Mission Pharmacal Corporation Information
11.2.2 Mission Pharmacal Description, Business Overview and Total Revenue
11.2.3 Mission Pharmacal Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Mission Pharmacal Amebiasis Products Offered
11.2.5 Mission Pharmacal Recent Development
11.3 Aceto Corporation
11.3.1 Aceto Corporation Corporation Information
11.3.2 Aceto Corporation Description, Business Overview and Total Revenue
11.3.3 Aceto Corporation Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Aceto Corporation Amebiasis Products Offered
11.3.5 Aceto Corporation Recent Development
11.4 Mylan Pharmaceuticals
11.4.1 Mylan Pharmaceuticals Corporation Information
11.4.2 Mylan Pharmaceuticals Description, Business Overview and Total Revenue
11.4.3 Mylan Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Mylan Pharmaceuticals Amebiasis Products Offered
11.4.5 Mylan Pharmaceuticals Recent Development
11.5 Impax Laboratories
11.5.1 Impax Laboratories Corporation Information
11.5.2 Impax Laboratories Description, Business Overview and Total Revenue
11.5.3 Impax Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Impax Laboratories Amebiasis Products Offered
11.5.5 Impax Laboratories Recent Development
11.6 Pfizer
11.6.1 Pfizer Corporation Information
11.6.2 Pfizer Description, Business Overview and Total Revenue
11.6.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Pfizer Amebiasis Products Offered
11.6.5 Pfizer Recent Development
11.7 Sanofi
11.7.1 Sanofi Corporation Information
11.7.2 Sanofi Description, Business Overview and Total Revenue
11.7.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sanofi Amebiasis Products Offered
11.7.5 Sanofi Recent Development
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Corporation Information
11.8.2 Lupin Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Lupin Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Lupin Pharmaceuticals Amebiasis Products Offered
11.8.5 Lupin Pharmaceuticals Recent Development
11.9 Glenmark Pharmaceuticals
11.9.1 Glenmark Pharmaceuticals Corporation Information
11.9.2 Glenmark Pharmaceuticals Description, Business Overview and Total Revenue
11.9.3 Glenmark Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Glenmark Pharmaceuticals Amebiasis Products Offered
11.9.5 Glenmark Pharmaceuticals Recent Development
11.10 Sun Pharmaceutical
11.10.1 Sun Pharmaceutical Corporation Information
11.10.2 Sun Pharmaceutical Description, Business Overview and Total Revenue
11.10.3 Sun Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Sun Pharmaceutical Amebiasis Products Offered
11.10.5 Sun Pharmaceutical Recent Development
11.1 Dr. Reddys Laboratories
11.1.1 Dr. Reddys Laboratories Corporation Information
11.1.2 Dr. Reddys Laboratories Description, Business Overview and Total Revenue
11.1.3 Dr. Reddys Laboratories Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Dr. Reddys Laboratories Amebiasis Products Offered
11.1.5 Dr. Reddys Laboratories Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Amebiasis Market Estimates and Projections by Region
12.1.1 Global Amebiasis Sales Forecast by Regions 2021-2026
12.1.2 Global Amebiasis Revenue Forecast by Regions 2021-2026
12.2 North America Amebiasis Market Size Forecast (2021-2026)
12.2.1 North America: Amebiasis Sales Forecast (2021-2026)
12.2.2 North America: Amebiasis Revenue Forecast (2021-2026)
12.2.3 North America: Amebiasis Market Size Forecast by Country (2021-2026)
12.3 Europe Amebiasis Market Size Forecast (2021-2026)
12.3.1 Europe: Amebiasis Sales Forecast (2021-2026)
12.3.2 Europe: Amebiasis Revenue Forecast (2021-2026)
12.3.3 Europe: Amebiasis Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Amebiasis Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Amebiasis Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Amebiasis Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Amebiasis Market Size Forecast by Region (2021-2026)
12.5 Latin America Amebiasis Market Size Forecast (2021-2026)
12.5.1 Latin America: Amebiasis Sales Forecast (2021-2026)
12.5.2 Latin America: Amebiasis Revenue Forecast (2021-2026)
12.5.3 Latin America: Amebiasis Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Amebiasis Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Amebiasis Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Amebiasis Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Amebiasis Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porters Five Forces Analysis
13.5 Primary Interviews with Key Amebiasis Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Amebiasis Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of Table
List of Tables
Table 1. Amebiasis Market Segments
Table 2. Ranking of Global Top Amebiasis Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Amebiasis Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Metronidazole
Table 5. Major Manufacturers of Paromomycin
Table 6. Major Manufacturers of Tinidazole
Table 7. Major Manufacturers of Other
Table 8. COVID-19 Impact Global Market: (Four Amebiasis Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Amebiasis Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Amebiasis Players to Combat Covid-19 Impact
Table 13. Global Amebiasis Market Size Growth Rate by Application 2020-2026 (K MT)
Table 14. Global Amebiasis Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 15. Global Amebiasis Sales by Regions 2015-2020 (K MT)
Table 16. Global Amebiasis Sales Market Share by Regions (2015-2020)
Table 17. Global Amebiasis Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Amebiasis Sales by Manufacturers (2015-2020) (K MT)
Table 19. Global Amebiasis Sales Share by Manufacturers (2015-2020)
Table 20. Global Amebiasis Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Amebiasis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amebiasis as of 2019)
Table 22. Amebiasis Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Amebiasis Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Amebiasis Price (2015-2020) (USD/MT)
Table 25. Amebiasis Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Amebiasis Product Type
Table 27. Date of International Manufacturers Enter into Amebiasis Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Amebiasis Sales by Type (2015-2020) (K MT)
Table 30. Global Amebiasis Sales Share by Type (2015-2020)
Table 31. Global Amebiasis Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Amebiasis Revenue Share by Type (2015-2020)
Table 33. Amebiasis Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 34. Global Amebiasis Sales by Application (2015-2020) (K MT)
Table 35. Global Amebiasis Sales Share by Application (2015-2020)
Table 36. North America Amebiasis Sales by Country (2015-2020) (K MT)
Table 37. North America Amebiasis Sales Market Share by Country (2015-2020)
Table 38. North America Amebiasis Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Amebiasis Revenue Market Share by Country (2015-2020)
Table 40. North America Amebiasis Sales by Type (2015-2020) (K MT)
Table 41. North America Amebiasis Sales Market Share by Type (2015-2020)
Table 42. North America Amebiasis Sales by Application (2015-2020) (K MT)
Table 43. North America Amebiasis Sales Market Share by Application (2015-2020)
Table 44. Europe Amebiasis Sales by Country (2015-2020) (K MT)
Table 45. Europe Amebiasis Sales Market Share by Country (2015-2020)
Table 46. Europe Amebiasis Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Amebiasis Revenue Market Share by Country (2015-2020)
Table 48. Europe Amebiasis Sales by Type (2015-2020) (K MT)
Table 49. Europe Amebiasis Sales Market Share by Type (2015-2020)
Table 50. Europe Amebiasis Sales by Application (2015-2020) (K MT)
Table 51. Europe Amebiasis Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Amebiasis Sales by Region (2015-2020) (K MT)
Table 53. Asia Pacific Amebiasis Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Amebiasis Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Amebiasis Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Amebiasis Sales by Type (2015-2020) (K MT)
Table 57. Asia Pacific Amebiasis Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Amebiasis Sales by Application (2015-2020) (K MT)
Table 59. Asia Pacific Amebiasis Sales Market Share by Application (2015-2020)
Table 60. Latin America Amebiasis Sales by Country (2015-2020) (K MT)
Table 61. Latin America Amebiasis Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Amebiasis Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Amebiasis Revenue Market Share by Country (2015-2020)
Table 64. Latin America Amebiasis Sales by Type (2015-2020) (K MT)
Table 65. Latin America Amebiasis Sales Market Share by Type (2015-2020)
Table 66. Latin America Amebiasis Sales by Application (2015-2020) (K MT)
Table 67. Latin America Amebiasis Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Amebiasis Sales by Country (2015-2020) (K MT)
Table 69. Middle East and Africa Amebiasis Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Amebiasis Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Amebiasis Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Amebiasis Sales by Type (2015-2020) (K MT)
Table 73. Middle East and Africa Amebiasis Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Amebiasis Sales by Application (2015-2020) (K MT)
Table 75. Middle East and Africa Amebiasis Sales Market Share by Application (2015-2020)
Table 76. Dr. Reddys Laboratories Corporation Information
Table 77. Dr. Reddys Laboratories Description and Major Businesses
Table 78. Dr. Reddys Laboratories Amebiasis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Dr. Reddys Laboratories Product
Table 80. Dr. Reddys Laboratories Recent Development
Table 81. Mission Pharmacal Corporation Information
Table 82. Mission Pharmacal Description and Major Businesses
Table 83. Mission Pharmacal Amebiasis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Mission Pharmacal Product
Table 85. Mission Pharmacal Recent Development
Table 86. Aceto Corporation Corporation Information
Table 87. Aceto Corporation Description and Major Businesses
Table 88. Aceto Corporation Amebiasis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Aceto Corporation Product
Table 90. Aceto Corporation Recent Development
Table 91. Mylan Pharmaceuticals Corporation Information
Table 92. Mylan Pharmaceuticals Description and Major Businesses
Table 93. Mylan Pharmaceuticals Amebiasis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. Mylan Pharmaceuticals Product
Table 95. Mylan Pharmaceuticals Recent Development
Table 96. Impax Laboratories Corporation Information
Table 97. Impax Laboratories Description and Major Businesses
Table 98. Impax Laboratories Amebiasis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Impax Laboratories Product
Table 100. Impax Laboratories Recent Development
Table 101. Pfizer Corporation Information
Table 102. Pfizer Description and Major Businesses
Table 103. Pfizer Amebiasis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Pfizer Product
Table 105. Pfizer Recent Development
Table 106. Sanofi Corporation Information
Table 107. Sanofi Description and Major Businesses
Table 108. Sanofi Amebiasis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. Sanofi Product
Table 110. Sanofi Recent Development
Table 111. Lupin Pharmaceuticals Corporation Information
Table 112. Lupin Pharmaceuticals Description and Major Businesses
Table 113. Lupin Pharmaceuticals Amebiasis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. Lupin Pharmaceuticals Product
Table 115. Lupin Pharmaceuticals Recent Development
Table 116. Glenmark Pharmaceuticals Corporation Information
Table 117. Glenmark Pharmaceuticals Description and Major Businesses
Table 118. Glenmark Pharmaceuticals Amebiasis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Glenmark Pharmaceuticals Product
Table 120. Glenmark Pharmaceuticals Recent Development
Table 121. Sun Pharmaceutical Corporation Information
Table 122. Sun Pharmaceutical Description and Major Businesses
Table 123. Sun Pharmaceutical Amebiasis Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. Sun Pharmaceutical Product
Table 125. Sun Pharmaceutical Recent Development
Table 126. Heritage Pharmaceuticals Corporation Information
Table 127. Heritage Pharmaceuticals Description and Major Businesses
Table 128. Heritage Pharmaceuticals Amebiasis Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 129. Heritage Pharmaceuticals Product
Table 130. Heritage Pharmaceuticals Recent Development
Table 131. Global Amebiasis Sales Forecast by Regions (2021-2026) (K MT)
Table 132. Global Amebiasis Sales Market Share Forecast by Regions (2021-2026)
Table 133. Global Amebiasis Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 134. Global Amebiasis Revenue Market Share Forecast by Regions (2021-2026)
Table 135. North America: Amebiasis Sales Forecast by Country (2021-2026) (K MT)
Table 136. North America: Amebiasis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 137. Europe: Amebiasis Sales Forecast by Country (2021-2026) (K MT)
Table 138. Europe: Amebiasis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 139. Asia Pacific: Amebiasis Sales Forecast by Region (2021-2026) (K MT)
Table 140. Asia Pacific: Amebiasis Revenue Forecast by Region (2021-2026) (US$ Million)
Table 141. Latin America: Amebiasis Sales Forecast by Country (2021-2026) (K MT)
Table 142. Latin America: Amebiasis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Middle East and Africa: Amebiasis Sales Forecast by Country (2021-2026) (K MT)
Table 144. Middle East and Africa: Amebiasis Revenue Forecast by Country (2021-2026) (US$ Million)
Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 146. Key Challenges
Table 147. Market Risks
Table 148. Main Points Interviewed from Key Amebiasis Players
Table 149. Amebiasis Customers List
Table 150. Amebiasis Distributors List
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Amebiasis Product Picture
Figure 2. Global Amebiasis Sales Market Share by Type in 2020 & 2026
Figure 3. Metronidazole Product Picture
Figure 4. Paromomycin Product Picture
Figure 5. Tinidazole Product Picture
Figure 6. Other Product Picture
Figure 7. Global Amebiasis Sales Market Share by Application in 2020 & 2026
Figure 8. Hospital
Figure 9. Pharmacy
Figure 10. Amebiasis Report Years Considered
Figure 11. Global Amebiasis Market Size 2015-2026 (US$ Million)
Figure 12. Global Amebiasis Sales 2015-2026 (K MT)
Figure 13. Global Amebiasis Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Amebiasis Sales Market Share by Region (2015-2020)
Figure 15. Global Amebiasis Sales Market Share by Region in 2019
Figure 16. Global Amebiasis Revenue Market Share by Region (2015-2020)
Figure 17. Global Amebiasis Revenue Market Share by Region in 2019
Figure 18. Global Amebiasis Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Amebiasis Revenue in 2019
Figure 20. Amebiasis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Amebiasis Sales Market Share by Type (2015-2020)
Figure 22. Global Amebiasis Sales Market Share by Type in 2019
Figure 23. Global Amebiasis Revenue Market Share by Type (2015-2020)
Figure 24. Global Amebiasis Revenue Market Share by Type in 2019
Figure 25. Global Amebiasis Market Share by Price Range (2015-2020)
Figure 26. Global Amebiasis Sales Market Share by Application (2015-2020)
Figure 27. Global Amebiasis Sales Market Share by Application in 2019
Figure 28. Global Amebiasis Revenue Market Share by Application (2015-2020)
Figure 29. Global Amebiasis Revenue Market Share by Application in 2019
Figure 30. North America Amebiasis Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Amebiasis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Amebiasis Sales Market Share by Country in 2019
Figure 33. North America Amebiasis Revenue Market Share by Country in 2019
Figure 34. U.S. Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Amebiasis Market Share by Type in 2019
Figure 39. North America Amebiasis Market Share by Application in 2019
Figure 40. Europe Amebiasis Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Amebiasis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Amebiasis Sales Market Share by Country in 2019
Figure 43. Europe Amebiasis Revenue Market Share by Country in 2019
Figure 44. Germany Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Amebiasis Market Share by Type in 2019
Figure 55. Europe Amebiasis Market Share by Application in 2019
Figure 56. Asia Pacific Amebiasis Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Amebiasis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Amebiasis Sales Market Share by Region in 2019
Figure 59. Asia Pacific Amebiasis Revenue Market Share by Region in 2019
Figure 60. China Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Amebiasis Market Share by Type in 2019
Figure 83. Asia Pacific Amebiasis Market Share by Application in 2019
Figure 84. Latin America Amebiasis Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Amebiasis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Amebiasis Sales Market Share by Country in 2019
Figure 87. Latin America Amebiasis Revenue Market Share by Country in 2019
Figure 88. Mexico Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Amebiasis Market Share by Type in 2019
Figure 95. Latin America Amebiasis Market Share by Application in 2019
Figure 96. Middle East and Africa Amebiasis Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Amebiasis Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Amebiasis Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Amebiasis Revenue Market Share by Country in 2019
Figure 100. Turkey Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Amebiasis Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Amebiasis Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Amebiasis Market Share by Type in 2019
Figure 107. Middle East and Africa Amebiasis Market Share by Application in 2019
Figure 108. Dr. Reddys Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 109. Mission Pharmacal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Aceto Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Mylan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Impax Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Lupin Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Glenmark Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Heritage Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Amebiasis Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. North America Amebiasis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Amebiasis Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Europe Amebiasis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Amebiasis Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Asia Pacific Amebiasis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Amebiasis Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Latin America Amebiasis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Amebiasis Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 128. Middle East and Africa Amebiasis Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
Request Discount 
Inquire Before Buy
